TARGET HEALTHCARE REIT PLC |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 76.6 GBX | -2.05% |
|
+1.46% | -11.24% |
| Apr. 12 | JPMorgan raises Taylor Wimpey, Persimmon | AN |
| Mar. 12 | Target Healthcare interim net asset value and contractual rent grow | AN |
| Sales 2024 * | 71.4M 88.98M | Sales 2025 * | 73.17M 91.18M | Capitalization | 475M 592M |
|---|---|---|---|---|---|
| Net income 2024 * | 64M 79.76M | Net income 2025 * | 65M 81M | EV / Sales 2024 * | 9.89 x |
| Net Debt 2024 * | 231M 288M | Net Debt 2025 * | 256M 319M | EV / Sales 2025 * | 10 x |
| P/E ratio 2024 * |
7.3
x | P/E ratio 2025 * |
7.28
x | Employees | - |
| Yield 2024 * |
7.44% | Yield 2025 * |
7.61% | Free-Float | 99.9% |
More Fundamentals
* Assessed data
More news
More press releases
| 1 day | -2.05% | ||
| 1 week | +1.46% | ||
| Current month | -9.03% | ||
| 1 month | -7.71% | ||
| 3 months | -8.70% | ||
| 6 months | +2.13% | ||
| Current year | -11.24% |
1 week
75.50
79.00
1 month
75.0084.50
Current year
75.0088.90
1 year
66.3088.90
3 years
65.70126.00
5 years
65.58126.00
10 years
65.58126.00
| Managers | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 74 | - | |
Gordon Bland
DFI | Director of Finance/CFO | 45 | - |
John Flannelly
CIO | Chief Investment Officer | 49 | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Vince Niblett
BRD | Director/Board Member | - | 21-08-24 |
Richard Cotton
BRD | Director/Board Member | 68 | 22-10-31 |
Michael Brodtman
BRD | Director/Board Member | 64 | 22-12-31 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.00% | 10 M€ | -3.35% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-24 | 76.6 | -2.05% | 583,103 |
| 24-04-23 | 78.2 | +0.13% | 617,015 |
| 24-04-22 | 78.1 | +0.90% | 844,397 |
| 24-04-19 | 77.4 | +1.18% | 1,347,920 |
| 24-04-18 | 76.5 | +1.32% | 3,003,824 |
Delayed Quote London S.E., April 24, 2024 at 11:35 am EDT
More quotes
Target Healthcare REIT plc is a United Kingdom-based real estate investment company. The Companyâs investment objective is to provide shareholders with an attractive level of income, together with the potential for capital and income growth, from investing in a diversified portfolio of freehold and long leasehold care homes that are let to care home operators; and other healthcare assets in the United Kingdom. Its portfolio comprised 97 properties let to 32 tenants. The Company invests in modern, purpose-built care homes that are let to tenants who demonstrate operational capabilities and a care ethos. Its portfolio includes Chawley Grove, Roden Hall, The Oaks, Chesterfield, Woodland View and The Manor. The Company invests in a portfolio of care homes, predominantly in the United Kingdom, which are let to care home operators on full repairing and insuring leases. Its investment manager and alternative investment fund manager is Target Fund Managers Limited.
Sector
Residential REITs
Calendar
2024-10-07
- Q4 2024 Earnings Release (Projected)
Trading Rating
Investor Rating
ESG Refinitiv
D+
Sell
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
0.766
GBP
Average target price
0.995
GBP
Spread / Average Target
+29.90%
EPS Revisions
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -11.24% | 603M | |
| +2.20% | 26.79B | |
| +5.64% | 23.91B | |
| +0.59% | 20.9B | |
| -0.08% | 15.55B | |
| -9.99% | 14.96B | |
| -4.51% | 14.88B | |
| -1.08% | 13.04B | |
| -1.04% | 12.27B | |
| -13.07% | 11.52B |
- Stock Market
- Equities
- THRL Stock
